#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4415964	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 10 uM by Western blot analysis	Homo sapiens	14		cell-based format	Scientific Literature
2.	ALA4415965	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation by Western blot analysis	Homo sapiens	7		cell-based format	Scientific Literature
3.	ALA4415967	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 1 to 100 nM by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
4.	ALA4415968	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 100 nM by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
5.	ALA4415977	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 100 nM incubated up to 24 hrs by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
6.	ALA4415979	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation pre-treated with 4 uM VHL1 for 2 hrs followed by compound addition at 100 nM and further incubated for 8 hrs by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
7.	ALA4415980	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation pre-treated with 100 nM dasatinib for 2 hrs followed by compound addition at 100 nM and further incubated for 8 hrs by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
8.	ALA4415981	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation pre-treated with 2.5 uM proteasome inhibitor MG132 for 2 hrs followed by compound addition at 100 nM and further incubated for 8 hrs by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
9.	ALA4415982	B	Induction of ternary complex formation between VHL and BCR-ABL (unknown origin) using recombinant ABL kinase domain and recombinant VHL/EloB/EloC by SEC-MALS analysis	Homo sapiens	3		protein format	Scientific Literature
10.	ALA4415983	B	Protac activity against VHL/BCR-ABL in human K562 cell lysates assessed as induction of pull down of endogenous BCR-ABL at 10 to 100 nM in presence of excess immobilized GST-VBC bait by GST-pull down assay	Homo sapiens	1		subcellular format	Scientific Literature
11.	ALA4415984	B	Protac activity against VHL/BCR-ABL in human K562 cell lysates assessed as induction of pull down of endogenous ABL at 10 to 100 nM in presence of excess immobilized GST-VBC bait by GST-pull down assay	Homo sapiens	1		subcellular format	Scientific Literature
12.	ALA4415985	B	Induction of ternary complex formation between VHL and BCR-ABL (unknown origin) expressed in HEK293 cells expressing N-terminal BCR-ABL LgBit fusion protein and N-terminal SmBit-VHL fusion protein at 1 uM incubated for 1 hr by NanoBit technology based luciferase complementation assay	Homo sapiens	2		cell-based format	Scientific Literature
13.	ALA4415986	B	Induction of ternary complex formation between VHL and BCR-ABL (unknown origin) expressed in HEK293 cells expressing N-terminal BCR-ABL LgBit fusion protein and N-terminal SmBit-VHL fusion protein pre-treated with 10 uM dasatinib for 2 hrs followed by compound addition at 1 uM and further incubated for 1 hr by NanoBit technology based luciferase complementation assay	Homo sapiens	1		cell-based format	Scientific Literature
14.	ALA4415990	B	Induction of ternary complex formation between VHL and BCR-ABL (unknown origin) expressed in HEK293 cells expressing N-terminal BCR-ABL LgBit fusion protein and N-terminal SmBit-VHL fusion protein incubated for 1 hr by NanoBit technology based luciferase complementation assay	Homo sapiens	2		cell-based format	Scientific Literature
15.	ALA4415991	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as reduction in ABL2 protein levels at 100 nM incubated for 16 hrs by multiplexed tandem mass spectrometry	Homo sapiens	1		cell-based format	Scientific Literature
16.	ALA4415994	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL protein levels at 1 to 100 nM incubated for 16 hrs by by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
17.	ALA4416011	B	Protac activity against VHL/BCR-ABL (unknown origin) expressed in human U937 cells assessed as induction of BCR-ABL degradation incubated for 16 hrs by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
18.	ALA4416013	B	Protac activity against VHL/BCR-ABL V299L mutant (unknown origin) expressed in human U937 cells assessed as induction of BCR-ABL degradation incubated for 16 hrs by Western blot analysis	Homo sapiens	1		cell-based format	Scientific Literature
19.	ALA4416020	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as induction of BCR-ABL degradation at 20 times IC50 incubated for 12 hrs followed by drug wash-out and incubation in drug-free medium up to 72 hrs by Western blot analysis	Homo sapiens	3		cell-based format	Scientific Literature
20.	ALA4416021	B	Protac activity against VHL/BCR-ABL in human K562 cells assessed as reduction in BCR-ABL phosphorylation at 20 times IC50 incubated for 12 hrs followed by drug wash-out and incubation in drug-free medium up to 72 hrs by Western blot analysis	Homo sapiens	3		cell-based format	Scientific Literature